How much can we gain from improved efficiency? An examination of performance of national HIV/AIDS programs and its determinants in low- and middle-income countries

BMC Health Serv Res. 2012 Mar 24:12:74. doi: 10.1186/1472-6963-12-74.

Abstract

Background: The economic downturn exacerbates the inadequacy of resources for combating the worldwide HIV/AIDS pandemic and amplifies the need to improve the efficiency of HIV/AIDS programs.

Methods: We used data envelopment analysis (DEA) to evaluate efficiency of national HIV/AIDS programs in transforming funding into services and implemented a Tobit model to identify determinants of the efficiency in 68 low- and middle-income countries. We considered the change from the lowest quartile to the average value of a variable a "notable" increase.

Results: Overall, the average efficiency in implementing HIV/AIDS programs was moderate (49.8%). Program efficiency varied enormously among countries with means by quartile of efficiency of 13.0%, 36.4%, 54.4% and 96.5%. A country's governance, financing mechanisms, and economic and demographic characteristics influence the program efficiency. For example, if countries achieved a notable increase in "voice and accountability" (e.g., greater participation of civil society in policy making), the efficiency of their HIV/AIDS programs would increase by 40.8%. For countries in the lowest quartile of per capita gross national income (GNI), a notable increase in per capita GNI would increase the efficiency of AIDS programs by 45.0%.

Conclusions: There may be substantial opportunity for improving the efficiency of AIDS services, by providing more services with existing resources. Actions beyond the health sector could be important factors affecting HIV/AIDS service delivery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acquired Immunodeficiency Syndrome* / prevention & control
  • Acquired Immunodeficiency Syndrome* / therapy
  • Developing Countries*
  • Epidemiologic Factors
  • Government Regulation
  • HIV Infections* / prevention & control
  • HIV Infections* / therapy
  • Health Expenditures
  • Health Priorities* / legislation & jurisprudence
  • Health Priorities* / standards
  • Humans
  • Interinstitutional Relations
  • National Health Programs / standards*
  • Population Surveillance
  • Program Evaluation
  • Quality Assurance, Health Care* / methods
  • Social Control, Formal
  • Social Responsibility